Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 546581 - 546600 out of 553687 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC02) basiliximab (adm: P, course dose) | SIMULECT 20MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | NovartisPharmaceuticalsCorporation |
| USA | (L04AC02) basiliximab (adm: P, course dose) | SIMULECT 20MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | NovartisPharmaceuticalsCorporation |
| USA | (L04AC03) anakinra (adm: P) | KINERET 100MG/0.67ML INJ,SYRINGE | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection | Sobi,Inc. |
| USA | (L04AC03) anakinra (adm: P) | KINERET 100MG/0.67ML INJ,SYRINGE | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;COVID-19 virus infection | Sobi,Inc. |
| USA | (L04AC04) rilonacept (adm: P) | ARCALYST 220MG VIL | 1X4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | KiniksaPharmaceuticals(UK),Ltd. |
| USA | (L04AC04) rilonacept (adm: P) | ARCALYST 220MG VIL | 1X4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | KiniksaPharmaceuticals(UK),Ltd. |
| USA | (L04AC05) ustekinumab (adm: P) | SELARSDI 45MG/0.5ML INJ,SYR,0.5ML | 0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L04AC05) ustekinumab (adm: P) | SELARSDI 45MG/0.5ML INJ,SYR,0.5ML | 0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L04AC05) ustekinumab (adm: P) | SELARSDI 90MG/ML INJ,SYR | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L04AC05) ustekinumab (adm: P) | SELARSDI 90MG/ML INJ,SYR | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L04AC05) ustekinumab (adm: P) | USTEKINUMAB-TTWE 45MG/0.5ML INJ,SYR,0.5ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | QuallentPharmaceuticalsHealthLLC |
| USA | (L04AC05) ustekinumab (adm: P) | USTEKINUMAB-TTWE 90MG/ML INJ,SYR,1ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | QuallentPharmaceuticalsHealthLLC |
| USA | (L04AC05) ustekinumab (adm: P) | OTULFI 5MG/ML INJ,SOLN,26ML | 26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative | FreseniusKabi,LLC |
| USA | (L04AC05) ustekinumab (adm: P) | OTULFI 5MG/ML INJ,SOLN,26ML | 26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative | FreseniusKabi,LLC |
| USA | (L04AC05) ustekinumab (adm: P) | PYZCHIVA 5MG/ML INJ,SOLN,26ML | 26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative;Arthritis, Psoriatic | Sandoz,Inc. |
| USA | (L04AC05) ustekinumab (adm: P) | STELARA 130MG/26ML IV VIAL | 1X26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC05) ustekinumab (adm: P) | STELARA 130MG/26ML IV VIAL | 1X26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC05) ustekinumab (adm: P) | STEQEYMA 5MG/ML INJ,SOLN,26ML | 26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | CelltrionUSA,Inc. |
| USA | (L04AC05) ustekinumab (adm: P) | YESINTEK 5MG/ML INJ,SOLN,26ML | 26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | BioconBiologics,Inc. |
| USA | (L04AC05) ustekinumab (adm: P) | YESINTEK 5MG/ML INJ,SOLN,26ML | 26ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | BioconBiologics,Inc. |
Pages
